A public health approach to cervical cancer control: considerations of screening and vaccination strategies.
Cervical cancer remains a leading cause of cancer death among women living in low-resource settings. In the last 3 decades, cytologic screening has -in theory -been available and yet more than 6 million women have died of this preventable disease. The necessary resources, infrastructure, and technological expertise, together with the need for repeated screenings at regular intervals, make cytologic screening difficult to implement in poor countries. As noncytologic approaches for the detection of HPV, simple visual screening methods for anogenital lesions caused by HPV, and the availability of an HPV-16/18 vaccine will enhance the linkage between screening and treatment, multiple factors will need to be considered when designing new, or modifying existing prevention strategies. Countryspecific decisions regarding the best strategy for cervical cancer control will need to rely on data from many sources and take into account complex epidemiologic, economic, social, political, and cultural factors, and be made despite uncertainty and incomplete information. A rigorous decision analytic approach using computerbased modeling methods enables linkage of the knowledge gained from empirical studies to real-world situations. This chapter provides an introduction to these methods, reviews lessons learned from cost-effectiveness analyses of cervical cancer screening in developed and developing countries, and emphasizes important qualitative themes to consider in designing cervical cancer prevention policies.
Goldie
Sue
S
Department of Health Policy and Management, Program in Health Descision Science, Boston, MA 02115, USA. sue_goldie@harvard.edu
D000328:Adult; D005260:Female; D052162:Human papillomavirus 16 / Q000276:immunology / Q000302:isolation & purification; D052161:Human papillomavirus 18 / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000191:economics / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D011634:Public Health; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000276:immunology / Q000517:prevention & control* / Q000821:virology*
D053918:Papillomavirus Vaccines